Form 8-K - Current report:
SEC Accession No. 0001104659-20-121393
Filing Date
2020-11-04
Accepted
2020-11-04 16:50:17
Documents
14
Period of Report
2020-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2034855d2_8k.htm   iXBRL 8-K 25784
2 EXHIBIT 99.1 tm2034855d2_ex99-1.htm EX-99.1 189314
6 GRAPHIC image_001.jpg GRAPHIC 4389
  Complete submission text file 0001104659-20-121393.txt   413007

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20201104.xsd EX-101.SCH 3174
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20201104_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20201104_pre.xml EX-101.PRE 22702
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2034855d2_8k_htm.xml XML 3674
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 201287349
SIC: 2834 Pharmaceutical Preparations